References
Brenta G. The association between obesity and the thyroid: is the “Chicken or the Egg” conundrum finally solved? J Clin Endocrinol Metab. 2021; https://doi.org/10.1210/clinem/dgab291.
Wiesner A, Gajewska D, Paśko P. Levothyroxine interactions with food and dietary supplements. a systematic review. Pharmaceuticals (Basel). 2021;14(3):206.
Iannelli A, Treacy P, Sebastianelli L, et al. Perioperative complications of sleeve gastrectomy: review of the literature. J Minim Access Surg. 2019;15(1):1–7.
Ianiro G, Mangiola F, Di Rienzo TA, et al. A levothyroxine absorption in health and disease, and new therapeutic perspectives. Eur Rev Med Pharmacol Sci. 2014;18(4):451–6.
Virili C, Brusca N, Capriello S, et al. Levothyroxine therapy in gastric malabsorptive disorders. Front Endocrinol (Lausanne). 2021;11:621616. https://doi.org/10.3389/fendo.2020.621616.
Pirola I, Formenti AM, Gandossi E, et al. Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg. 2013;23(9):1493–6.
Fain K, Rojas AP, Peiris AN. Hypothyroidism following gastric sleeve surgery resolved by ingesting crushed thyroxine tablets. Proc (Baylor Univ Med Cent). 2019;33(1):38–9.
Porat D, Vaynshtein J, Gibori R, et al. Stomach pH before vs. after different bariatric surgery procedures: clinical implications for drug delivery. Eur J Pharm Biopharm. 2021;160:152–7.
Huang R, Ding X, Fu H, et al. Potential mechanisms of sleeve gastrectomy for reducing weight and improving metabolism in patients with obesity. Surg Obes Relat Dis. 2019;15(10):1861–71.
Eligar V, Taylor PN, Okosieme OE, et al. Thyroxine replacement: a clinical endocrinologist’s viewpoint. Ann Clin Biochem. 2016;53(Pt 4):421–33.
Elbanna H, Emile S, El-Hawary GE, et al. Assessment of the correlation between preoperative and immediate postoperative gastric volume and weight loss after sleeve gastrectomy using computed tomography volumetry. World J Surg. 2019;43(1):199–206.
Guzman-Prado Y, Vita R, Samson O. Concomitant use of levothyroxine and proton pump inhibitors in patients with primary hypothyroidism: a systematic review. J Gen Intern Med. 2021;36:1726–33. https://doi.org/10.1007/s11606-020-06403-y.
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–751.
Virili C, Giovanella L, Fallahi P, et al. Levothyroxine therapy: changes of TSH levels by switching patients from tablet to liquid formulation. a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2018;9:10.
Author information
Authors and Affiliations
Contributions
LS, AG, VI, FD, VP: patient care, concept, and design, drafting, revision. AF: the supervisor, revising critically. All authors discussed the content of the manuscript, read, and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
Informed consent was obtained from the individual patient included in the study
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schiavo, L., Giosuè, A., Izzo, V. et al. Liquid levothyroxine sodium therapy improves pharmacologic thyroid-stimulating hormone homeostasis in patients with reduced efficacy for tablet levothyroxine sodium after sleeve gastrectomy. A case report. OBES SURG 31, 4649–4652 (2021). https://doi.org/10.1007/s11695-021-05518-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-021-05518-3